leadf
logo-loader
viewHaystack Sciences

Haystack Sciences aims to help biotechs discover new drugs with its nDexer technology

Haystack Sciences CEO Eddie Watts sat down with Proactive at the BIO Investor Forum in San Francisco. 

San Francisco-based, privately-held Haystack is developing methods for drug discovery to help find new cures for difficult-to-treat disorders using its indexer technology.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

CO2 GRO sees 20% higher pepper yields though 10 weeks of Hidroexpo Feasibility

CO2 GRO (CVE: GROW- OTCQB: BLONF) Vice President of Sales and Strategic Alliances Aaron Archibald joined Steve Darling from Proactive to bring details the company has seen very good results from their CO2 Delivery Solution commercial feasibility on greenhouse-grown peppers with Hidroexpo in...

6 hours, 18 minutes ago

2 min read